- Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
Headquartered in Sydney, Australia, Pharmaxis also has offices in the US and UK.
The company's first product, Aridol, is approved for sale in Australia, the United States, major European countries and Korea. Eight distributors have been appointed to market Aridol in Europe and Asia.
Distributors